Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of reduced-volume PMF104 bowel preparation versus SELG 1000 before colonoscopy
2008-007144-33Phase 3Completed
- Sponsor
- Promefarm
- Start
- Jan 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of polyethylene glycol + citrate + simethicone (2 arms), sponsored by Promefarm. Primary endpoint: Quality of bowel preparation. Started Jan 2009; status: completed.
02
Drugs
polyethylene glycol + citrate + simethicone
Beyond the preview
Go deeper on 2008-007144-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007144-33.